Rational treatment of acute rhinosinusitis in children
DOI:
https://doi.org/10.15574/SP.2025.4(148).2935Keywords:
children, аcute rhinosinusitis, rhinorrhea, nasal symptoms, clinical efficacy, CinnabsinAbstract
Acute rhinosinusitis is among the most common respiratory conditions in children, particularly during periods of active socialization and immunological immaturity. Despite its predominantly viral etiology, antibiotics are frequently prescribed inappropriately, emphasizing the need for safe and effective pathogenetic treatment strategies.
Aim - to assess the clinical efficacy and tolerability of the complex homeopathic medicinal product Cinnabsin in the treatment of acute viral rhinosinusitis in children, compared to standard symptomatic therapy.
Materials and methods. A total of 65 children aged 5-15 years with signs of acute upper respiratory tract infection were enrolled in this observational study. The treatment group (n=36) received Cinnabsin along with nasal saline irrigation, while the control group (n=29) was treated with nasal saline irrigation, decongestants, and mucoactive agents. Clinical symptoms were evaluated on days 3 and 7 using a 5-point Visual Analogue Scale (VAS), an objective symptom severity score, and odds ratios (OR) to quantify treatment effects. Treatment tolerability was assessed based on parental and physician ratings.
Results. By day 3, the treatment group showed a more pronounced reduction in key nasal symptoms, particularly nasal obstruction and rhinorrhea. On day 7, significant improvement was observed in the treatment group (p<0.05), with ORs ranging from 2.38 to 5.86 in favour of the treatment group. Tolerability was rated as "Very good" in 94.4% of cases, and no adverse effects associated with Cinnabsin were reported.
Conclusions. Cinnabsin demonstrated high clinical efficacy and excellent tolerability in the management of acute viral rhinosinusitis in children, particularly in alleviating nasal symptoms. These findings support its use as a rational pathogenetic therapy in pediatric clinical practice.
The study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Local Ethics Committee for all participants. The informed consent was obtained from patients.
The author declares no conflict of interest.
References
Arcimowicz M. (2024). Rational treatment of acute rhinosinusitis in the context of increasing antibiotic resistance. Otolaryngol Pol. 78(6): 1-11. https://doi.org/10.5604/01.3001.0054.7506; PMid:39540274
Calatayud-Sáez FM. (2022). The traditional Mediterranean diet is effective in the prevention and treatment of acute and recurrent inflammatory diseases of childhood. Allergol Immunopathol (Madr). 50(2): 93-95. https://doi.org/10.15586/aei.v50i2.565; PMid:35257551
Fletcher R, Fletcher S, Wagner E. (2004). Clinical Epidemiology. Fundamentals of Evidence-Based Medicine. Media Sphere: 352.
Friese K, Zabolotny D. (2007). Homeopathie bei acuterinosinusitis. HNO. 55: 271-277. https://doi.org/10.1007/s00106-006-1480-x; PMid:17180695
Jaume F, Valls-Mateus M, Mullol J. (2020). Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020. Curr Allergy Asthma Rep. 20(7): 28. https://doi.org/10.1007/s11882-020-00917-5; PMid:32495003 PMCid:PMC7266914
Mathie RT, Fok YYY, Viksveen P et al. (2019). Systematic Review and Meta-Analysis of Randomised, Other-than-Placebo Controlled, Trials of Non-Individualised Homeopathic Treatment. Homeopathy. 108(2): 88-101. https://doi.org/10.1055/s-0038-1677481; PMid:30699444
Mathie RT, Ramparsad N, Legg LA et al. (2017). Randomised, double-blind, placebo-controlled trials of non-individualised homeopathic treatment: systematic review and meta-analysis. Syst Rev. 6(1): 63. https://doi.org/10.1186/s13643-017-0445-3; PMid:28340607 PMCid:PMC5366148
Mathie RT, Van Wassenhoven M, Rutten ALB et al. (2017). Model validity of randomised placebo-controlled trials of non-individualised homeopathic treatment. Homeopathy. 106(4): 194-202. https://doi.org/10.1016/j.homp.2017.07.003; PMid:29157469
Melnikov OF, Zabolotnaya DD, Zayats TA et al. (2019). Immunomodulatory properties of the Cinnabsin medicine. Otorhinolaryngology. 2-3(2): 53-57. https://doi.org/10.37219/8253-2019-2-53
Wannasuphoprasit Y, Bhutta MF. (2025). Management of acute rhinosinusitis in children. Paediatr Respir Rev. 22: S1526-0542(25)00034-X. https://doi.org/10.1016/j.prrv.2025.04.004; PMid:40368679
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
